On the Leading Edge: New Drug Therapies and Patient Management Practices for the HIV Patient

Participate in this satellite symposium at ID Week. Hear the latest in new HIV treatment.
1.50 available credits
Participate in this satellite symposium at ID Week. Hear the latest in new HIV treatment.
1.50 available credits
Enroll in this meeting
October 03, 2018
07:00 AM - 09:00 AM PDT
Moscone Center South, Rooms 206-208
747 Howard St, San Francisco, California, United States
Moscone Center
Enrollment Fee
  • Overview

    Although a multitude of therapies are available for the treatment of HIV, patients continue to experience treatment failure due to the development of resistance or toxicity. As a result, there remains an unmet need for new medications with better safety profiles, simpler regimens, and increased efficacy. Participate in this satellite symposium to learn more! Breakfast will be provided.


    This satellite symposium precedes IDWeekTM October 3-7, 2018. For more information, please visit here. 

  • Program Schedule*

    • Innovations and new therapies
    • Current treatment options
    • Suppression rates, metabolic side effects, and safety profiles of various treatment approaches
    • Local education approach
    • Environmental and geographic variances
    • Prescribing HIV treatment in "patient appropriate" manner
    • Cost effectiveness, formulary access, regional preferences, meeting treatment goals

    *Topics subject to change

  • Learning Objectives

    • Evaluate the utility of new therapies for HIV to reduce toxicities and improve efficacy of treatment
    • Assess the advantages of once-daily fixed dose combination drug therapy in a single tablet in reducing pill burden and improving treatment adherence
    • Discuss strategies to provide better care that is patient-centered, reliable, accessible, and safe
  • Target Audience

    This activity is designed to meet the educational needs of HIV and infectious disease specialists, including: physicians, nurse practitioners, physician assistants, and nurses. 

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Commercial Support

    This activity is supported by an independent educational grant from Merck. 

Facebook Comments

Sign up for the Prova Education newsletters.

Better education for a better you.

* Required

We’re glad to see you’re enjoying Prova Education…
but how about a more personalized experience?

Register for free